Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

Tuesday’s trading has closed, but DEPO is being traded in the after-hours session. After-Hours quote »
30.80
Delayed Data
As of 3:59pm ET
 -0.37 / -1.19%
Today’s Change
10.49
Today|||52-Week Range
33.74
+91.19%
Year-to-Date

Today’s Trading

Previous close31.17
Today’s open31.39
Day’s range30.79 - 31.62
Volume1,424,905
Average volume (3 months)2,120,032
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+173.33%
Earnings growth (this year)+102.56%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+190.87%
P/E ratio20.0
Price/Sales2.74
Price/Book5.07

Competitors

 Today’s
change
Today’s
% change
DNAIProNAi Therapeutics ...+0.71+2.49%
VBLTVascular Biogenics L...-0.07-1.22%
NEPTNeptune Technologies...-0.01-0.71%
TEVATeva Pharmaceutical+0.63+0.90%
Data as of 4:01pm ET, 08/04/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$0.18
Annual revenue (last year)$390.4M
Annual profit (last year)$131.8M
Net profit margin33.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts